BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 1542386)

  • 1. Differences of regional cerebral glucose metabolism between presenile and senile dementia of Alzheimer type.
    Mielke R; Herholz K; Grond M; Kessler J; Heiss WD
    Neurobiol Aging; 1992; 13(1):93-8. PubMed ID: 1542386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Difference of regional cerebral metabolic pattern between presenile and senile dementia of the Alzheimer type: a factor analytic study.
    Ichimiya A; Herholz K; Mielke R; Kessler J; Slansky I; Heiss WD
    J Neurol Sci; 1994 May; 123(1-2):11-7. PubMed ID: 8064302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HMPAO SPET and FDG PET in Alzheimer's disease and vascular dementia: comparison of perfusion and metabolic pattern.
    Mielke R; Pietrzyk U; Jacobs A; Fink GR; Ichimiya A; Kessler J; Herholz K; Heiss WD
    Eur J Nucl Med; 1994 Oct; 21(10):1052-60. PubMed ID: 7828614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired metabolic activation in Alzheimer's disease: a PET study during continuous visual recognition.
    Kessler J; Herholz K; Grond M; Heiss WD
    Neuropsychologia; 1991; 29(3):229-43. PubMed ID: 2057055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDG PET and differential diagnosis of dementia.
    Herholz K
    Alzheimer Dis Assoc Disord; 1995; 9(1):6-16. PubMed ID: 7605624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormalities of energy metabolism in Alzheimer's disease studied with PET.
    Heiss WD; Szelies B; Kessler J; Herholz K
    Ann N Y Acad Sci; 1991; 640():65-71. PubMed ID: 1776760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron emission tomography for diagnosis of Alzheimer's disease and vascular dementia.
    Mielke R; Heiss WD
    J Neural Transm Suppl; 1998; 53():237-50. PubMed ID: 9700661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron emission tomography in Alzheimer's disease.
    Duara R; Grady C; Haxby J; Sundaram M; Cutler NR; Heston L; Moore A; Schlageter N; Larson S; Rapoport SI
    Neurology; 1986 Jul; 36(7):879-87. PubMed ID: 3487046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomographic studies of aging and Alzheimer disease.
    de Leon MJ; Ferris SH; George AE; Christman DR; Fowler JS; Gentes C; Reisberg B; Gee B; Emmerich M; Yonekura Y; Brodie J; Kricheff II; Wolf AP
    AJNR Am J Neuroradiol; 1983; 4(3):568-71. PubMed ID: 6410799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional cerebral metabolic alterations in dementia of the Alzheimer type: positron emission tomography with [18F]fluorodeoxyglucose.
    Friedland RP; Budinger TF; Ganz E; Yano Y; Mathis CA; Koss B; Ober BA; Huesman RH; Derenzo SE
    J Comput Assist Tomogr; 1983 Aug; 7(4):590-8. PubMed ID: 6602819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral metabolism, anatomy, and cognition in monozygotic twins discordant for dementia of the Alzheimer type.
    Luxenberg JS; May C; Haxby JV; Grady C; Moore A; Berg G; White BJ; Robinette D; Rapoport SI
    J Neurol Neurosurg Psychiatry; 1987 Mar; 50(3):333-40. PubMed ID: 3494105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral metabolic and cognitive studies in dementia with frontal lobe behavioral features.
    Kumar A; Schapiro MB; Haxby JV; Grady CL; Friedland RP
    J Psychiatr Res; 1990; 24(2):97-109. PubMed ID: 2213642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative analysis of PET and MRI data in normal aging and Alzheimer's disease: atrophy weighted total brain metabolism and absolute whole brain metabolism as reliable discriminators.
    Alavi A; Newberg AB; Souder E; Berlin JA
    J Nucl Med; 1993 Oct; 34(10):1681-7. PubMed ID: 8410281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative topographical EEG compared to FDG PET for classification of vascular and degenerative dementia.
    Szelies B; Mielke R; Herholz K; Heiss WD
    Electroencephalogr Clin Neurophysiol; 1994 Aug; 91(2):131-9. PubMed ID: 7519142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain Metabolism of Less-Educated Patients With Alzheimer Dementia Studied by Positron Emission Tomography.
    Huang YC; Yen PS; Wu ST; Chen JT; Hung GU; Kao CH; Chen TY; Ho FM
    Medicine (Baltimore); 2015 Jul; 94(30):e1252. PubMed ID: 26222866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomography in degenerative disorders of the dopaminergic system.
    Karbe H; Holthoff V; Huber M; Herholz K; Wienhard K; Wagner R; Heiss WD
    J Neural Transm Park Dis Dement Sect; 1992; 4(2):121-30. PubMed ID: 1571076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P300 in Alzheimer's disease: relationships to dementia severity and glucose metabolism.
    Szelies B; Mielke R; Grond M; Heiss WD
    J Neurol Sci; 1995 May; 130(1):77-81. PubMed ID: 7650534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison study of positron emission tomography, X-ray CT and MRI in parkinsonism with dementia].
    Okada J; Peppard R; Calne DB
    Nihon Igaku Hoshasen Gakkai Zasshi; 1989 May; 49(5):643-56. PubMed ID: 2798056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional cerebral glucose transport and utilization in Alzheimer's disease.
    Friedland RP; Jagust WJ; Huesman RH; Koss E; Knittel B; Mathis CA; Ober BA; Mazoyer BM; Budinger TF
    Neurology; 1989 Nov; 39(11):1427-34. PubMed ID: 2812318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of positron emission tomography, cognition, and brain volume in Alzheimer's disease with and without severe abnormalities of white matter.
    DeCarli C; Grady CL; Clark CM; Katz DA; Brady DR; Murphy DG; Haxby JV; Salerno JA; Gillette JA; Gonzalez-Aviles A; Rapoport SI
    J Neurol Neurosurg Psychiatry; 1996 Feb; 60(2):158-67. PubMed ID: 8708645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.